The Research Institute occupies more than 500,000 square feet of dedicated research space on the Nationwide Children's Hospital campus. We are one of the largest pediatric research centers in the United States and are ranked among the top 10 for National Institutes of Health funding among free-standing children's hospitals
The Centers are structured to support multidisciplinary team science and discovery, enabled by outstanding shared resources. Each is home to 5-15 faculty members working in contiguous space, along with talented staff, graduate students, residents, postdoctoral fellows and other students.
Innovation and commercialization are ingrained in our culture. Scientists are supported by an outstanding cadre of technology commercialization experts. The Office of Technology Commercialization, formed in 2008, already has a remarkable track record of moving discoveries into the marketplace.
Collegiality and collaboration are the bywords at The Research Institute. Our vital role within the Nationwide Children's Hospital enterprise and our academic affiliation with The Ohio State University fosters an affiliative environment that integrates clinical and research resources, encourages dynamic exchange of ideas and supports team science.
Learn about our collaborations »
We are committed to identifying new approaches for the prevention, diagnosis and treatment of childhood diseases, taking research discoveries from the lab to the patient's bedside. Learn about our current studies below:
Children Needed for MRI-Speech Study
Children ages 4-12 years old with 22q11.2 deletion syndrome (also known as velocardiofacial/DiGeorge syndrome) are needed for a non-invasive MRI-speech study. Read more.
Heavy Menstrual Bleeding Study for Adolescent Girls
The purpose of this study is to learn more about an FDA-approved drug called tranexamic acid (also known as Lysteda) to determine whether or not it can decrease menstrual blood loss and increase quality of life for young women. Read more.
Established Status Epilepticus Treatment Trial (ESETT)
Nationwide Children's Hospital is one of forty sites in the United States participating in this multi-center research study designed to find out which of three commonly used, FDA-approved drugs best stops established status epilepticus. Read more.